(Q59268041)

title

Yellow fever vaccine: past, present and future (English)

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

19 May 2020

author name string

Anna H Roukens

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

19 May 2020

language of work or name

English

0 references

publication date

10 October 2008

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

19 May 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

19 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

19 May 2020

page(s)

1787-1795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

Treatment of yellow fever

19 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

The transmission of yellow fever to Macacus rhesus. 1928.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

The Behavior of the Virus of Yellow Fever in Monkeys and Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

The use of yellow fever virus modified by in vitro cultivation for human immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Rare case of fatal yellow fever vaccine-associated viscerotropic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever vaccine-associated viscerotropic disease and death in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Acute viscerotropic disease following vaccination against yellow fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever vaccination: how much is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

History of thymoma and yellow fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever vaccine is safe and effective in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Yellow fever vaccination and pregnancy: a four-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Early exposure to yellow fever vaccine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Congenital yellow fever virus infection after immunization in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Infectious disease. Resurgence of yellow fever in Africa prompts a counterattack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Pressure-inactivated yellow fever 17DD virus: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

A live, attenuated recombinant West Nile virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

New developments in flavivirus vaccines with special attention to yellow fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Prevention of yellow fever in persons traveling to the tropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Rarity of adverse effects after 17D yellow-fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.11.1787

10.1517/14712598.8.11.1787

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18847312%20AND%20SRC:MED&resulttype=core&format=json

19 May 2020

1 reference